LINC01848

Across TCGA pan-cancer cohorts, LINC01848 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC01848 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC01848 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01848 expression acts as an unfavorable survival marker, although some lineages such as LUAD and GBM show a favorable association.

MESO, LUSC, and LUAD are the cancer types where LINC01848 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.075	0.584	<.001	180	view →
LUSC	OS	Tertile	III,IV	0.366	0.718	.001	75	view →
LUAD	OS	Tertile	II,III,IV	0.855	0.672	.003	51	view →
STAD	OS	Tertile	All	0.119	0.568	<.001	36	view →
PCPG	OS	Tertile	All	0.755	0.959	.009	33	view →
LAML	DFS	Tertile	All	0.389	0.634	.016	20	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	18	view →
GBM	DFS	Tertile	All	0.713	0.195	.028	18	view →
KIRC	DFS	Tertile	IV	0.268	0.633	.002	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →
LIHC	DFS	Tertile	All	0.442	0.576	.039	9	view →
ACC	DFS	Tertile	II,III,IV	0.730	0.473	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC01848–MESO (OS)

Open the MESO breakdown →